A/Prof Michael Back (MBBS FRANZCR GradDipPsyOnc MBA PhD) is the Director of Radiation Oncology at the Northern Sydney Cancer Centre and has been specialising in the management of brain tumours for almost 25 years. He has been active in developing and expanding multidisciplinary neuro-oncology services in major university teaching hospitals within NSW and South East Asia. With a strong emphasis on patient-centred care and empowerment through information provision, he has generated a large clinical practice encompassing latest evidence-based care, technology, research and clinical trials. His major research interest is exploring the patterns of infiltration of brain tumours to improve upon the techniques used in radiation therapy.

A/Prof Back is a conjoint associate professor at the Sydney Medical School, University of Sydney. He is also a Visiting Medical Officer at the Central Coast Cancer Centre and a consultant at Genesis Cancer Care Australia. Previous specialty positions include the Newcastle Mater Hospital, Singapore National Neuroscience Institute and the Singapore National University Hospital.

Prof Andrew Kneebone is a senior staff specialist in Radiation Oncology at the Northern Sydney Cancer Centre. He has over 20 years' experience, as a leading genito-urinary and gastro-intestinal cancer specialist. He has been a chief investigator in many clinical trials, attracting nearly $12 million from 13 competitive grants from national and international organisations.

Prof Kneebone was the chair of the national Radiation Oncology Genitourinary Executive (FROGG) and the Radiation Oncology Executive for the Australian Gastro-Intestinal Trials Group (AGITG). He is the co-chair and CIA for NHMRCs 'RAVES' trial, evaluating optimal timing for post prostatectomy radiotherapy. His work presented at ASTRO in 2019, was selected as one of the top 4 genito-urinary abstracts, and as best presentation.

Prof Kneebone is on several state and national committees including NHMRC and the NSW Cancer Institute advisory committee. His work has led to more than 110 peer reviewed publications, numerous published national guidelines, and he has been an invited speaker at more than 90 conferences or meetings. With a strong commitment to education, he is a Clinical Professor with the University of Sydney and continues to teach medical students and junior doctors.

A/Prof Thomas Eade returned to RNSH in January 2007, after time spent working as the Thomas Baker Fellow at the Fox Chase Cancer Center in Philadelphia, USA. Fox Chase is one of the leading specialist centres to treat prostate cancer in the USA. A/Prof Eade trained in the latest radiation therapy techniques including IMRT, intra-operative real-time seed brachytherapy and high dose rate brachytherapy.

Recognised across the country for his expertise in the IMRT/VMAT and IGRT techniques for the treatment of prostate cancer, he has led the way for the NSCC to become one of the leading prostate cancer radiation treatment centres in Australia and he has been a guest speaker at state, national and international meetings on advanced radiation techniques.

In addition to his strong patient care and outcome focus, A/Prof Eade is also a committed researcher and has published in major international oncology journals. He is the Director of Research in Radiation Oncology at NSCC and also developed the prospective database for prostate cancer radiotherapy, which is in use across the North Shore and Central Coast campuses. A key area of interest for him is in researching and evaluating the delivery of new technology in radiotherapy.

Dr Gillian Lamouray is a Radiation Oncologist at the Northern Sydney Cancer Centre at Royal North Shore Hospital, with a sub-speciality interest in the treatment of breast cancer. Her postgraduate study was completed at the St Vincent's/ Garvan Research Institute into the molecular sub-typing of breast cancer, after obtaining her fellowship. She is the recent Chair of the Breast Cancer Advisory Group (Cancer Australia) 2018 -2020.

Dr Lamouray was inaugural Chair of BIG-FRO (2014), the Breast Interest Group- Faculty of Radiation Oncology, and a member of the Australasian Society of Breast Disease and the ANZ Breast Cancer Trials Group. She is also a member of the Strategic Advisory Group for Breast Cancer Network Australia (BCNA), and of the Cancer Australia Guide to Early Breast Cancer Steering Committee.

Dr Lamouray is actively involved in quality assurance programs and clinical trials and is Principal Investigator on a number of innovative breast cancer trials at the Northern Sydney Cancer Centre.  She is a senior lecturer the Northern Clinical School. Gillian is passionate about patient-centred care and the delivery of high-quality treatments through state-of-the-art and innovative radiotherapy techniques for breast cancer. Her philanthropic interests and passion for equitable access to high quality cancer treatments have led to her accepting a position on the Board of the GenesisCare Foundation (2020).

Dr Mark Stevens is a senior staff specialist Radiation Oncologist at the Northern Sydney Cancer Centre. He has special interests in head & neck, gynaecologic and lung cancers. High dose-rate brachytherapy within these sub-sites and for partial breast radiation are a major focus. He has achieved a BSc (Medicine) in immunology (University of Queensland) as well as his MMBS. He has completed a Master of Medicine in Pain Management (University of Sydney).

Dr Stevens completed specialist training at Royal North Shore Hospital and Royal Prince Alfred Hospital. He was then appointed as the inaugural Bob Champion Trust Uro-oncology Research Fellow at the Royal Marsden Hospital in London where he was awarded RANZCRs C.E. Eddy Prize and the Thomas Baker Fellowship. In 1991 he was appointed staff specialist at RNSH and granted dual fractional HMO status at St Vincent's Private and Public Hospitals in 1995. In 2002, Dr Stevens co-founded the Riverina Cancer Care Centre (Wagga Wagga) which first established integrated radiation and chemotherapy treatment, multi-disciplinary tumour boards, and remote patient accommodation infrastructure within a regional NSW community. He was on-site Director of this service 2006-2009 prior to re-joining RNSH, NSCC.

Dr Marita Morgia undertook specialist Radiation Oncology training at the Wollongong Hospital and Royal North Shore Hospital before completing a clinical research fellowship at the Princess Margaret Hospital in Toronto, Canada. Her research and subspecialty training was in breast and gynaecological malignancies. She returned in 2011 to join the Northern Cancer Centre at Royal North Shore Hospital as a staff specialist.

Dr Morgia has an interest in the management of breast, gynaecological, gastrointestinal, and haematological malignancies. She has been instrumental in developing protocols within her institution, including pelvic intensity modulated radiotherapy (IMRT), MRI-guided brachytherapy, breast IMRT and a modified deep inspiration breath-hold technique in breast radiotherapy to spare the heart. She is actively involved in research as well as clinical trial recruitment in these subspecialty areas and has published in both national and international peer-reviewed journals. Dr Morgia is a member of Trans-Tasman Radiation Oncology Group (TROG), the Australasian Society for Breast Disease (ASBD), Australia and New Zealand Breast Cancer Trials Group (ANZBCTCG) and is on the executive for the RANZCR breast special interest group BIG-FRO.

A/Prof George Hruby is a Radiation Oncologist at the Northern Sydney Cancer Centre with advanced training, research and clinical specialty interest in both genito-urinary and gastro-intestinal cancers.

In Dec 2000 he commenced as a Staff Specialist in Radiation Oncology at Royal Prince Alfred Hospital.  Specialisations included genito-urinary and gastro-intestinal malignancies as well as melanoma and merkel cell carcinoma.  He also established a close working relationship with the urologists in Noumea and has treated many New Caledonian men with cancer over the years.

A/Prof Hruby established the High Dose Rate brachytherapy program at Royal Prince Alfred (RPA) Hospital performing over 300 implants since its inception in 2002.  He was instrumental in introducing image guided radiation treatment (IGRT) in 2007 and IMRT in 2009 for the treatment of prostate cancer at RPA.   In 2014, A/Prof Hruby was invited to join the specialised Radiation Oncology team as a staff specialist at Royal North Shore.

A/Prof Hruby has been heavily involved in local, national and international trials and is an active participant in TROG, FROOGG and ANZUP. He is an advocate of Radiation Oncology, and is often called upon to speak at conferences, prostate cancer forums or to teach colleagues. George has also authored over 100 peer reviewed publications.

A/Prof Susan Carroll has had over 20 years' experience working in some Sydney's major hospitals whilst subspecialising in breast cancer, haematological and lower gastrointestinal malignancies. After graduating from the University of NSW, she completed her specialist training at Prince of Wales Hospital. She then moved to Royal Prince Alfred Hospital/Chris O'Brien Lifehouse for over a decade, before joining the team at Royal North Shore Hospital. She is a member of the Breast Trials Group and the International Radiation Oncology Lymphoma Group, making her an integral member of the multidisciplinary teams at RNSH.

A/Prof Carroll areas of research interests in in the development of new treatment techniques to improve outcomes within her speciality areas. She has been invited to both national and international meetings where she was recognised as an expert in her work on breast cancer and haematological malignancies. She embraces a holistic approach to care in her daily practice. As a Clinical Associate Professor with the University of Sydney Medical School, she is continuously working on the innovation of treatment techniques and the improvement of patient outcomes.

​Dr Dasantha Jayamanne has been a Radiation Oncologist at the Northern Sydney Cancer Centre since 2016. He completed his training at the Crown Princess Mary Hospital before undertaking a fellowship role in central nervous system (CNS) and head and neck (NH) malignancies at RNSH. He currently leads the lung radiation oncology sub-specialty service and is an active member of the head and neck and CNS tumour streams. He has completed a Diploma in Palliative Medicine and is also currently completing a PhD in lung cancer tracking and Stereotactic Ablative Body Radiotherapy (SBRT).

Dr Jayamanne is committed to research and education. He has an active academic portfolio, with numerous publications in medical journals, and has presented his work at both national and international meetings. He has strong links to RANZCR and is the Director of Training in Radiation Oncology at RNSH. He is also an active member of TROG (Trans Tasman Radiation Oncology Group), COSA (Clinical Oncology Society of Australia), TOGA (Thoracic Oncology Group of Australasia), COGNO (Cooperative Trials Group for Neuro-Oncology) and is the president of FROLIC (Faculty of Radiation Oncology Lung Interest Cooperative). Dr Jayamanne is an investigator in several national and international clinical trials and is passionate about evidence-based patient-centred care. Through his interest in clinical research, he is able to deliver high quality radiation therapy treatment and develop innovative treatment techniques.

​Dr Sarah Bergamin is a staff specialist in Radiation Oncology with sub-speciality interests in lung cancer, head and neck cancer and palliative radiotherapy. Graduating with first class honours from UNSW, she undertook specialist radiation oncology training at Royal North Shore Hospital, Westmead Hospital and The Chris O'Brien Lifehouse, and received the Kaye Scott Prize for the most outstanding performance in the Radiation Oncology examinations.

Dr Bergamin is committed to delivering personalised, high quality cancer care. She is an active member of the lung and head and neck multidisciplinary team at Royal North Shore Hospital, and the Australian and New Zealand Palliative Radiation Oncology Group. Dr Bergamin is an investigator on several national clinical trials, has presented at national and international meetings, and published in several oncology journals.

Dr Bergamin's other main interest is medical education and training. She has a Master of Health Professional Education and is a Clinical Associate Lecturer with the University of Sydney. She is co-chair of the RANZCR Radiation Oncology Mentor Program, is on the Radiation Oncology Post Fellowship Education Committee, and is part of the International Radiation Oncology Education Collaborative Study Group. She is actively involved in reviewing Cancer Institute NSW EVIQ radiation oncology treatment protocols and oncology educational modules.